114 related articles for article (PubMed ID: 28517405)
1. SU-D-213CD-05: Identifying Prostate Brachytherapy Seeds at MRI: A Study in Phantom.
Fatemi-Ardekani A; Borg J
Med Phys; 2012 Jun; 39(6Part3):3618. PubMed ID: 28517405
[TBL] [Abstract][Full Text] [Related]
2. Prostate post-implant dosimetry: interobserver variability in seed localisation, contouring and fusion.
De Brabandere M; Hoskin P; Haustermans K; Van den Heuvel F; Siebert FA
Radiother Oncol; 2012 Aug; 104(2):192-8. PubMed ID: 22857857
[TBL] [Abstract][Full Text] [Related]
3. Sci-Sat AM(2): Brachy-06: A Comparison of MR/CT fusion versus CT alone for assessment of implant quality in permanent prostate brachytherapy.
Sasaki DK; Malkoske K; Bews J; Cho P; Drachenberg D; Chowdhury A
Med Phys; 2008 Jul; 35(7Part3):3417. PubMed ID: 28512893
[TBL] [Abstract][Full Text] [Related]
4. The applicability of simultaneous TRUS-CT imaging for the evaluation of prostate seed implants.
Steggerda M; Schneider C; van Herk M; Zijp L; Moonen L; van der Poel H
Med Phys; 2005 Jul; 32(7Part1):2262-2270. PubMed ID: 28493573
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of seed reconstruction in prostate postplanning studied with a CT- and MRI-compatible phantom.
De Brabandere M; Kirisits C; Peeters R; Haustermans K; Van den Heuvel F
Radiother Oncol; 2006 May; 79(2):190-7. PubMed ID: 16707176
[TBL] [Abstract][Full Text] [Related]
6. MRI-based automated detection of implanted low dose rate (LDR) brachytherapy seeds using quantitative susceptibility mapping (QSM) and unsupervised machine learning (ML).
Nosrati R; Soliman A; Safigholi H; Hashemi M; Wronski M; Morton G; Pejović-Milić A; Stanisz G; Song WY
Radiother Oncol; 2018 Dec; 129(3):540-547. PubMed ID: 30243670
[TBL] [Abstract][Full Text] [Related]
7. CT, MR, and ultrasound image artifacts from prostate brachytherapy seed implants: the impact of seed size.
Robertson AK; Basran PS; Thomas SD; Wells D
Med Phys; 2012 Apr; 39(4):2061-8. PubMed ID: 22482627
[TBL] [Abstract][Full Text] [Related]
8. MRI of prostate brachytherapy seeds at high field: a study in phantom.
Thomas SD; Wachowicz K; Fallone BG
Med Phys; 2009 Nov; 36(11):5228-34. PubMed ID: 19994533
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of seed localization and dose calculation on pre- and post-implantation ultrasound and CT images for low-dose-rate prostate brachytherapy.
Ali I; Algan O; Thompson S; Sindhwani P; Herman T; Cheng CY; Ahmad S
Phys Med Biol; 2009 Sep; 54(18):5595-611. PubMed ID: 19717887
[TBL] [Abstract][Full Text] [Related]
10. Effect of pulse sequence parameter selection on signal strength in positive-contrast MRI markers for MRI-based prostate postimplant assessment.
Lim TY; Kudchadker RJ; Wang J; Stafford RJ; MacLellan C; Rao A; Ibbott GS; Frank SJ
Med Phys; 2016 Jul; 43(7):4312. PubMed ID: 27370146
[TBL] [Abstract][Full Text] [Related]
11. Impact of MRI-based postimplant dosimetric assessment in prostate brachytherapy using contrast-enhanced T1-weighted images.
Ohashi T; Momma T; Yamashita S; Nagatsuma K; Kanai K; Kitagawa K; Takahashi S; Hanada T; Yorozu A; Shigematsu N
Brachytherapy; 2012; 11(6):468-75. PubMed ID: 22330102
[TBL] [Abstract][Full Text] [Related]
12. A new two-step accurate CT-MRI fusion technique for post-implant prostate cancer.
Kunogi H; Hojo H; Wakumoto Y; Saito AI; Ishikura S; Yamashiro Y; Kuwatsuru R; Sasai K
J Contemp Brachytherapy; 2015 Apr; 7(2):117-21. PubMed ID: 26034491
[TBL] [Abstract][Full Text] [Related]
13. Using combined x-ray and MR imaging for prostate I-125 post-implant dosimetry: phantom validation and preliminary patient work.
Miquel ME; Rhode KS; Acher PL; Macdougall ND; Blackall J; Gaston RP; Hegde S; Morris SL; Beaney R; Deehan C; Popert R; Keevil SF
Phys Med Biol; 2006 Mar; 51(5):1129-37. PubMed ID: 16481682
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive I-125 multi-seed comparison for prostate brachytherapy: dosimetry and visibility analysis.
Al-Qaisieh B; Smith DW; Brearley E; St Clair S; Bownes P
Radiother Oncol; 2007 Aug; 84(2):140-7. PubMed ID: 17588696
[TBL] [Abstract][Full Text] [Related]
15. Development of a magnetic resonance imaging protocol to visualize encapsulated contrast agent markers in prostate brachytherapy recipients: initial patient experience.
Lim TY; Kudchadker RJ; Wang J; Bathala T; Szklaruk J; Pugh TJ; Mahmood U; Ibbott GS; Frank SJ
J Contemp Brachytherapy; 2016 Jun; 8(3):235-42. PubMed ID: 27504133
[TBL] [Abstract][Full Text] [Related]
16. The applicability of simultaneous TRUS-CT imaging for the evaluation of prostate seed implants.
Steggerda M; Schneider C; van Herk M; Zijp L; Moonen L; van der Poel H
Med Phys; 2005 Jul; 32(7):2262-70. PubMed ID: 16121581
[TBL] [Abstract][Full Text] [Related]
17. Permanent prostate brachytherapy postimplant magnetic resonance imaging dosimetry using positive contrast magnetic resonance imaging markers.
Martin GV; Pugh TJ; Mahmood U; Kudchadker RJ; Wang J; Bruno TL; Bathala T; Blanchard P; Frank SJ
Brachytherapy; 2017; 16(4):761-769. PubMed ID: 28501429
[TBL] [Abstract][Full Text] [Related]
18. A dual modality phantom for cone beam CT and ultrasound image fusion in prostate implant.
Ng A; Beiki-Ardakan A; Tong S; Moseley D; Siewerdsen J; Jaffray D; Yeung IW
Med Phys; 2008 May; 35(5):2062-71. PubMed ID: 18561682
[TBL] [Abstract][Full Text] [Related]
19. Prostate postbrachytherapy seed distribution: comparison of high-resolution, contrast-enhanced, T1- and T2-weighted endorectal magnetic resonance imaging versus computed tomography: initial experience.
Bloch BN; Lenkinski RE; Helbich TH; Ngo L; Oismueller R; Jaromi S; Kubin K; Hawliczek R; Kaplan ID; Rofsky NM
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):70-8. PubMed ID: 17513062
[TBL] [Abstract][Full Text] [Related]
20. Use and uncertainties of mutual information for computed tomography/ magnetic resonance (CT/MR) registration post permanent implant of the prostate.
Roberson PL; McLaughlin PW; Narayana V; Troyer S; Hixson GV; Kessler ML
Med Phys; 2005 Feb; 32(2):473-82. PubMed ID: 15789594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
